Entod Research Cell

Entod Pharmaceuticals is a specialized pharmaceutical company headquartered in Mumbai, India, with a primary focus on ophthalmology, ENT, and dermatology. The Entod Research Cell (ERC) serves as the company's dedicated research and development division, focusing on the creation of innovative therapeutic formulations and drug delivery systems. Entod is recognized for its extensive portfolio of over 250 products, including eye drops, nasal sprays, and topical medications, which are exported to more than 55 countries. A notable recent achievement of the ERC is the development of PresVu, the first eye drop in India approved for the treatment of presbyopia. The company maintains state-of-the-art manufacturing facilities and is a key player in the global eye care market.